Trial intelligence / Profile preview

Gardasil for Prevention of AIN Recurrence in HIV+ MSM

NCT02087384Phase 4Completed

Start
Mar 2014
Primary completion
Jul 2018
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of qHPV vaccine in anal intraepithelial neoplasia (AIN). Started Mar 2014; status: completed.

02

Drugs

qHPV vaccine
03

Conditions

anal intraepithelial neoplasia (AIN)

Beyond the preview

Go deeper on NCT02087384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02087384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call